Gongqin Sun - Publications

Affiliations: 
Cell and Molecular Biology University of Rhode Island, Providence, RI, United States 
Area:
Biochemistry

65 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Chapdelaine AG, Ku GC, Sun G, Ayrapetov MK. The Targeted Degradation of BRAF V600E Reveals the Mechanisms of Resistance to BRAF-Targeted Treatments in Colorectal Cancer Cells. Cancers. 15. PMID 38136350 DOI: 10.3390/cancers15245805  0.693
2023 Sun G, Ayrapetov MK. Dissection of the catalytic and regulatory structure-function relationships of Csk protein tyrosine kinase. Frontiers in Cell and Developmental Biology. 11: 1148352. PMID 36936693 DOI: 10.3389/fcell.2023.1148352  0.805
2022 Ku GC, Chapdelaine AG, Ayrapetov MK, Sun G. Identification of Lethal Inhibitors and Inhibitor Combinations for Mono-Driver versus Multi-Driver Triple-Negative Breast Cancer Cells. Cancers. 14. PMID 36011019 DOI: 10.3390/cancers14164027  0.731
2020 Chen L, Marsiglia WM, Chen H, Katigbak J, Erdjument-Bromage H, Kemble DJ, Fu L, Ma J, Sun G, Zhang Y, Liang G, Neubert TA, Li X, Traaseth NJ, Mohammadi M. Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation. Nature Chemical Biology. PMID 31959966 DOI: 10.1038/S41589-019-0455-7  0.81
2019 Liu C, Mu X, Wang X, Zhang C, Zhang L, Yu B, Sun G. Ponatinib Inhibits Proliferation and Induces Apoptosis of Liver Cancer Cells, but Its Efficacy Is Compromised by Its Activation on PDK1/Akt/mTOR Signaling. Molecules (Basel, Switzerland). 24. PMID 30959969 DOI: 10.3390/molecules24071363  0.334
2019 Li L, Cui Y, Shen J, Dobson H, Sun G. Evidence for activated Lck protein tyrosine kinase as the driver of proliferation in acute myeloid leukemia cell, CTV-1. Leukemia Research. 78: 12-20. PMID 30660961 DOI: 10.1016/j.leukres.2019.01.006  0.397
2018 Cui Y, Sun G. Structural versatility that serves the function of the HRD motif in the catalytic loop of protein tyrosine kinase, Src. Protein Science : a Publication of the Protein Society. PMID 30461096 DOI: 10.1002/pro.3554  0.396
2016 Tiwari RK, Brown A, Shirazi AN, Bolton J, Tse A, Verkhivker G, Parang K, Sun G. Design, Synthesis, and Evaluation of Dasatinib-Amino Acid and Dasatinib-Fatty Acid Conjugates as Protein Tyrosine Kinase Inhibitors. Chemmedchem. PMID 27875633 DOI: 10.1002/Cmdc.201600387  0.359
2016 Li J, Qin S, Xu J, Xiong J, Wu C, Bai Y, Liu W, Tong J, Liu Y, Xu R, Wang Z, Wang Q, Ouyang X, Yang Y, Ba Y, ... ... Sun G, et al. Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 1448-54. PMID 26884585 DOI: 10.1200/JCO.2015.63.5995  0.358
2013 Sun G, Lin X, Shen L, Wu F, Xu D, Ruan K, Feng Y. Mono-PEGylated radix ophiopogonis polysaccharide for the treatment of myocardial ischemia. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 49: 629-36. PMID 23727058 DOI: 10.1016/j.ejps.2013.05.020  0.328
2013 Nasrolahi Shirazi A, Tiwari RK, Brown A, Mandal D, Sun G, Parang K. Cyclic peptides containing tryptophan and arginine as Src kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23: 3230-4. PMID 23602444 DOI: 10.1016/J.Bmcl.2013.03.124  0.458
2011 Sun G, Lin X, Wang Z, Feng Y, Xu D, Shen L. PEGylated inulin as long-circulating pharmaceutical carrier. Journal of Biomaterials Science. Polymer Edition. 22: 429-41. PMID 20566038 DOI: 10.1163/092050610X487729  0.35
2010 Sun GL, Lin X. [Mechanisms and strategies for targeting drugs to myocardial ischemic regions]. Yao Xue Xue Bao = Acta Pharmaceutica Sinica. 45: 827-32. PMID 20931778  0.325
2010 Lin X, Wang S, Jiang Y, Wang ZJ, Sun GL, Xu DS, Feng Y, Shen L. Poly(ethylene glycol)-radix Ophiopogonis polysaccharide conjugates: preparation, characterization, pharmacokinetics and in vitro bioactivity. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 76: 230-7. PMID 20633648 DOI: 10.1016/j.ejpb.2010.07.003  0.35
2010 Tiwari R, Brown A, Narramaneni S, Sun G, Parang K. Synthesis and evaluation of conformationally constrained peptide analogues as the Src SH3 domain binding ligands. Biochimie. 92: 1153-63. PMID 20109515 DOI: 10.1016/J.Biochi.2010.01.017  0.467
2010 Lin X, Wang Z, Sun G, Shen L, Xu D, Feng Y. A sensitive and specific HPGPC-FD method for the study of pharmacokinetics and tissue distribution of Radix Ophiopogonis polysaccharide in rats. Biomedical Chromatography : Bmc. 24: 820-5. PMID 20020416 DOI: 10.1002/bmc.1369  0.31
2009 Sun G, Kemble DJ. To C or not to C: direct and indirect redox regulation of Src protein tyrosine kinase. Cell Cycle (Georgetown, Tex.). 8: 2353-5. PMID 19571676 DOI: 10.4161/Cc.8.15.9225  0.802
2009 Ye G, Schuler AD, Ahmadibeni Y, Morgan JR, Faruqui A, Huang K, Sun G, Zebala JA, Parang K. Synthesis and evaluation of phosphopeptides containing iminodiacetate groups as binding ligands of the Src SH2 domain. Bioorganic Chemistry. 37: 133-42. PMID 19539345 DOI: 10.1016/J.Bioorg.2009.05.003  0.61
2009 Kemble DJ, Sun G. Direct and specific inactivation of protein tyrosine kinases in the Src and FGFR families by reversible cysteine oxidation. Proceedings of the National Academy of Sciences of the United States of America. 106: 5070-5. PMID 19273857 DOI: 10.1073/Pnas.0806117106  0.809
2009 Huang K, Wang YH, Brown A, Sun G. Identification of N-terminal lobe motifs that determine the kinase activity of the catalytic domains and regulatory strategies of Src and Csk protein tyrosine kinases. Journal of Molecular Biology. 386: 1066-77. PMID 19244618 DOI: 10.1016/J.Jmb.2009.01.012  0.694
2007 Wang YH, Huang K, Lin X, Sun G. Subdomain switching reveals regions that harbor substrate specificity and regulatory properties of protein tyrosine kinases. Biochemistry. 46: 10162-9. PMID 17691821 DOI: 10.1021/Bi7007257  0.77
2007 Ahmadibeni Y, Hanley M, White M, Ayrapetov M, Lin X, Sun G, Parang K. Metal-binding properties of a dicysteine-containing motif in protein tyrosine kinases. Chembiochem : a European Journal of Chemical Biology. 8: 1592-605. PMID 17674392 DOI: 10.1002/Cbic.200700242  0.788
2007 Ye G, Nam NH, Kumar A, Saleh A, Shenoy DB, Amiji MM, Lin X, Sun G, Parang K. Synthesis and evaluation of tripodal peptide analogues for cellular delivery of phosphopeptides. Journal of Medicinal Chemistry. 50: 3604-17. PMID 17580848 DOI: 10.1021/Jm070416O  0.442
2007 Kumar A, Wang Y, Lin X, Sun G, Parang K. Synthesis and evaluation of 3-phenylpyrazolo[3,4-d]pyrimidine-peptide conjugates as Src kinase inhibitors. Chemmedchem. 2: 1346-60. PMID 17530729 DOI: 10.1002/Cmdc.200700074  0.535
2006 Gu X, Wang Y, Kumar A, Ye G, Parang K, Sun G. Design and evaluation of hydroxamate derivatives as metal-mediated inhibitors of a protein tyrosine kinase. Journal of Medicinal Chemistry. 49: 7532-9. PMID 17149882 DOI: 10.1021/Jm061058C  0.498
2006 Kemble DJ, Wang YH, Sun G. Bacterial expression and characterization of catalytic loop mutants of SRC protein tyrosine kinase. Biochemistry. 45: 14749-54. PMID 17144667 DOI: 10.1021/Bi061664+  0.817
2006 Sun G, Sun L, Wen H, Jia Z, Huang K, Hu C. From layered double hydroxide to spinel nanostructures: facile synthesis and characterization of nanoplatelets and nanorods. The Journal of Physical Chemistry. B. 110: 13375-80. PMID 16821857 DOI: 10.1021/jp060916d  0.45
2006 Ayrapetov MK, Wang YH, Lin X, Gu X, Parang K, Sun G. Conformational basis for SH2-Tyr(P)527 binding in Src inactivation. The Journal of Biological Chemistry. 281: 23776-84. PMID 16790421 DOI: 10.1074/Jbc.M604219200  0.79
2006 Wang YH, Ayrapetov MK, Lin X, Sun G. A new strategy to produce active human Src from bacteria for biochemical study of its regulation. Biochemical and Biophysical Research Communications. 346: 606-11. PMID 16765913 DOI: 10.1016/J.Bbrc.2006.05.180  0.822
2006 Kumar A, Ye G, Wang Y, Lin X, Sun G, Parang K. Synthesis and structure-activity relationships of linear and conformationally constrained peptide analogues of CIYKYY as Src tyrosine kinase inhibitors. Journal of Medicinal Chemistry. 49: 3395-401. PMID 16722659 DOI: 10.1021/Jm060334K  0.522
2006 Lin X, Wang Y, Ahmadibeni Y, Parang K, Sun G. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase. Journal of Molecular Biology. 357: 1263-73. PMID 16483606 DOI: 10.1016/J.Jmb.2006.01.046  0.637
2006 Lee S, Ayrapetov MK, Kemble DJ, Parang K, Sun G. Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk). The Journal of Biological Chemistry. 281: 8183-9. PMID 16439366 DOI: 10.1074/Jbc.M508120200  0.802
2005 Lin X, Ayrapetov MK, Sun G. Characterization of the interactions between the active site of a protein tyrosine kinase and a divalent metal activator. Bmc Biochemistry. 6: 25. PMID 16305747 DOI: 10.1186/1471-2091-6-25  0.818
2005 Ye G, Ayrapetov M, Nam NH, Sun G, Parang K. Solid-phase binding assays of peptides using EGFP-Src SH2 domain fusion protein and biotinylated Src SH2 domain. Bioorganic & Medicinal Chemistry Letters. 15: 4994-7. PMID 16169725 DOI: 10.1016/J.Bmcl.2005.08.005  0.775
2005 Ayrapetov MK, Nam NH, Ye G, Kumar A, Parang K, Sun G. Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation. The Journal of Biological Chemistry. 280: 25780-7. PMID 15890649 DOI: 10.1074/Jbc.M504022200  0.799
2005 Sun G, Cao M, Wang Y, Hu C, Ren L, Huang K. Controlled synthesis of nanorods/nanorings of a novel Co-Cu complex in microemulsion at room temperature. Chemical Communications (Cambridge, England). 1740-2. PMID 15791317 DOI: 10.1039/b416222f  0.444
2005 Lin X, Ayrapetov MK, Lee S, Parang K, Sun G. Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk. Biochemistry. 44: 1561-7. PMID 15683240 DOI: 10.1021/Bi048142J  0.797
2005 Lieser SA, Shindler C, Aubol BE, Lee S, Sun G, Adams JA. Phosphoryl transfer step in the C-terminal Src kinase controls Src recognition. The Journal of Biological Chemistry. 280: 7769-76. PMID 15623523 DOI: 10.1074/Jbc.M411736200  0.534
2005 Parang K, Sun G. Recent advances in the discovery of Src kinase inhibitors Expert Opinion On Therapeutic Patents. 15: 1183-1207. DOI: 10.1517/13543776.15.9.1183  0.517
2004 Parang K, Sun G. Design strategies for protein kinase inhibitors. Current Opinion in Drug Discovery & Development. 7: 617-29. PMID 15503864  0.443
2004 Nam NH, Lee S, Ye G, Sun G, Parang K. ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases. Bioorganic & Medicinal Chemistry. 12: 5753-66. PMID 15498652 DOI: 10.1016/J.Bmc.2004.08.043  0.53
2004 Nam NH, Ye G, Sun G, Parang K. Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding. Journal of Medicinal Chemistry. 47: 3131-41. PMID 15163193 DOI: 10.1021/Jm040008+  0.376
2004 Nam NH, Pitts RL, Sun G, Sardari S, Tiemo A, Xie M, Yan B, Parang K. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain. Bioorganic & Medicinal Chemistry. 12: 779-87. PMID 14759738 DOI: 10.1016/J.Bmc.2003.10.060  0.425
2003 Lee S, Lin X, Nam NH, Parang K, Sun G. Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase. Proceedings of the National Academy of Sciences of the United States of America. 100: 14707-12. PMID 14657361 DOI: 10.1073/Pnas.2534493100  0.648
2003 Ayrapetov MK, Lee S, Sun G. Expression, purification, and biochemical characterization of Chk, a soluble protein tyrosine kinase. Protein Expression and Purification. 29: 148-55. PMID 12767803 DOI: 10.1016/S1046-5928(02)00698-8  0.809
2003 Lin X, Lee S, Sun G. Functions of the activation loop in Csk protein-tyrosine kinase. The Journal of Biological Chemistry. 278: 24072-7. PMID 12686554 DOI: 10.1074/Jbc.M210596200  0.612
2002 Lee S, Lin X, McMurray J, Sun G. Contribution of an active site cation-pi interaction to the spectroscopic properties and catalytic function of protein tyrosine kinase Csk. Biochemistry. 41: 12107-14. PMID 12356311 DOI: 10.1021/Bi026439G  0.626
2002 Sun G, Ramdas L, Wang W, Vinci J, McMurray J, Budde RJ. Effect of autophosphorylation on the catalytic and regulatory properties of protein tyrosine kinase Src. Archives of Biochemistry and Biophysics. 397: 11-7. PMID 11747305 DOI: 10.1006/Abbi.2001.2627  0.527
2001 Zeng Y, Huang K, Xu C, Zhang J, Sun G. Biorheological characteristics of skin after expansion. Biorheology. 38: 367-78. PMID 12016320  0.455
2001 Shaffer J, Sun G, Adams JA. Nucleotide release and associated conformational changes regulate function in the COOH-terminal Src kinase, Csk. Biochemistry. 40: 11149-55. PMID 11551213 DOI: 10.1021/Bi011029Y  0.478
2001 Sun G, Budde RJA. Affinity purification of Csk protein tyrosine kinase based on its catalytic requirement for divalent metal cations. Protein Expression and Purification. 21: 8-12. PMID 11162381 DOI: 10.1006/Prep.2000.1351  0.441
2001 Budde RJA, Ramdas L, Sun G. Cloning, expression, purification and characterization of the alternate splice Src variants for drug discovery Journal of Molecular Catalysis B-Enzymatic. 11: 805-809. DOI: 10.1016/S1381-1177(00)00058-8  0.428
2000 Wang W, Ramdas L, Sun G, Ke S, Obeyesekere NU, Budde RJA, McMurray JS. Cyclic peptides incorporating 4-carboxyphenylalanine and phosphotyrosine are potent inhibitors of pp60(c-src) Biochemistry. 39: 5221-5228. PMID 10819990 DOI: 10.1021/Bi992994F  0.5
1999 Ramdas L, Bunnin BA, Plunkett MJ, Sun G, Ellman J, Gallick GE, Budde RJA. Benzodiazepine Compounds As Inhibitors Of The Src Protein Tyrosine Kinase : Screening Of A Combinatorial Library Of 1,4-Benzodiazepines Archives of Biochemistry and Biophysics. 368: 394-400. PMID 10441393 DOI: 10.1006/Abbi.1999.1313  0.457
1999 Ramdas L, Obeyesekere NU, Sun G, McMurray JS, Budde RJA. N-myristoylation of a peptide substrate for Src converts it into an apparent slow-binding bisubstrate-type inhibitor Journal of Peptide Research. 53: 569-577. PMID 10424353 DOI: 10.1034/J.1399-3011.1999.00063.X  0.399
1999 Sun G, Budde RJA. Mutations in the N-terminal regulatory region reduce the catalytic activity of Csk, but do not affect its recognition of Src. Archives of Biochemistry and Biophysics. 367: 167-172. PMID 10395732 DOI: 10.1006/Abbi.1999.1253  0.561
1999 Sun G, Budde RJA. Substitution Studies of the Second Divalent Metal Cation Requirement of Protein Tyrosine Kinase CSK Biochemistry. 38: 5659-5665. PMID 10220355 DOI: 10.1021/Bi982793W  0.362
1998 Sun G, Sharma AK, Budde RJ. Autophosphorylation of Src and Yes blocks their inactivation by Csk phosphorylation. Oncogene. 17: 1587-1595. PMID 9794236 DOI: 10.1038/Sj.Onc.1202076  0.574
1997 Sun G, Budde RJA. Expression, Purification, and Initial Characterization of Human Yes Protein Tyrosine Kinase from a Bacterial Expression System Archives of Biochemistry and Biophysics. 345: 135-142. PMID 9281320 DOI: 10.1006/Abbi.1997.0236  0.513
1997 Sun G, Ke S, Budde RJA. Csk phosphorylation and inactivation in vitro by the cAMP-dependent protein kinase Archives of Biochemistry and Biophysics. 343: 194-200. PMID 9224730 DOI: 10.1006/Abbi.1997.0156  0.583
1997 Sun G, Budde RJA. Requirement for an additional divalent metal cation to activate protein tyrosine kinases. Biochemistry. 36: 2139-2146. PMID 9047313 DOI: 10.1021/Bi962291N  0.457
1995 Li S, Sun G, Budde RJA. Production and Characterization of Monoclonal Antibodies against the Recombinant p50csk Protein Tyrosine Kinase: A Tool for Signal Transduction Research Hybridoma. 14: 341-346. PMID 8522345 DOI: 10.1089/Hyb.1995.14.341  0.517
1993 Sun G, Sarath G, Markwell J. Phosphopeptides as substrates for thylakoid protein phosphatase activity Archives of Biochemistry and Biophysics. 304: 490-495. PMID 8394059 DOI: 10.1006/Abbi.1993.1380  0.43
1992 Sun G, Markwell J. Lack of Types 1 and 2A Protein Serine(P)/Threonine(P) Phosphatase Activities in Chloroplasts. Plant Physiology. 100: 620-624. PMID 16653037 DOI: 10.1104/Pp.100.2.620  0.395
1989 Sun G, Bailey D, Jones MW, Markwell J. Chloroplast Thylakoid Protein Phosphatase Is a Membrane Surface-Associated Activity Plant Physiology. 89: 238-243. PMID 16666520 DOI: 10.1104/Pp.89.1.238  0.349
Show low-probability matches.